Showing results (241-250 of 3,162) with videos related to
Sort By:
Pageof 317
Translational Oncology|July 9, 2021
The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid featuresYi-Wen Wang, Hsiang-Lin Song, Cheng-Yao Chiang, et al.Translational Oncology|July 10, 2021
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalizationGeorge Yang, Zhigang Yuan, Kamran Ahmed, et al.Translational Oncology|July 18, 2021
Early risk-assessment of patients with nasopharyngeal carcinoma: the added prognostic value of MR-based radiomicsMin-Jung Kim, Yangsean Choi, Yeoun Eun Sung, et al.Translational Oncology|July 22, 2021
Resistin: A journey from metabolism to cancerAnkita Deb, Bhavana Deshmukh, Pranay Ramteke, et al.Translational Oncology|July 22, 2021
Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learningHadi Moghadas-Dastjerdi, Shan-E-Tallat Hira Rahman, Lakshmanan Sannachi, et al.Translational Oncology|December 28, 2020
Progastrin production transitions from Bmi1+/Prox1+ to Lgr5high cells during early intestinal tumorigenesisJ Giraud, M Foroutan, J Boubaker-Vitre, et al.Translational Oncology|December 31, 2020
Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancerNingning Li, Chunmei Bai, Ruixing Zhang, et al.Translational Oncology|December 22, 2020
HPV DNA/RNA detection in various oral and oropharyngeal biomaterials identifies active HPV infections also in non-neoplastic tonsilsElgar Susanne Quabius, Silke Tribius, Alessa Heinrichs, et al.Translational Oncology|May 6, 2022
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironmentXianyu Zhang, Yunkai Yu, Cody J Peer, et al.Translational Oncology|May 6, 2022
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinomaZhen-Zhen Wang, Tao Meng, Ming-Ya Yang, et al.Pageof 317